BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/6/2021 7:03:21 AM | Browse: 1088 | Download: 2557
Publication Name World Journal of Nephrology
Manuscript ID 66534
Country Brazil
ISSN 2220-6124 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Retrospective Cohort Study
Article Title Should pediatric idiopathic hypercalciuria be treated with hypocalciuric agents?
Manuscript Source Invited Manuscript
All Author List Maria Goretti Moreira Guimarães Penido and Marcelo de Sousa Tavares
ORCID
Author(s) ORCID Number
Maria Goretti Moreira Guimarães Penido http://orcid.org/0000-0002-1534-3861
Marcelo de Sousa Tavares http://orcid.org/0000-0002-9766-9354
Funding Agency and Grant Number
Corresponding Author Maria Goretti Moreira Guimarães Penido, FRCP (Hon), MD, PhD, Associate Professor, Chief Doctor, Professor, Pediatric Nephrology Unit, Nephrology Center of Santa Casa de Belo Horizonte, Rua Piauí 420, Santa Efigênia, Belo Horizonte 30150320, Minas Gerais, Brazil. mariagorettipenido@yahoo.com.br
Key Words Children; Adolescent; Hypercalciuria; Bone mineral density; Thiazides; Citrate
Core Tip Should pediatric idiopathic hypercalciuria be treated with hypocalciuric agents? Reduction in bone mass has already been described in hypercalciuric pediatric patients and the precise mechanisms of bone loss or failure to achieve adequate bone mass remain unknown. Initial recommendations for the treatment of hypercalciuric pediatric patients consist of lifestyle changes and adequate diet. Children rarely comply with those recommendations and require potassium citrate supplementation or thiazides to reduce calciuria. However, anticalciuric therapy in children and adolescents is not based on strong clinical evidences. We speculate if the anticalciuric effect of pharmacologic therapy has a beneficial role on bone mass in pediatric idiopathic hypercalciuria and compromised bone mass in adulthood.
Publish Date 2021-08-06 07:03
Citation Penido MGMG, Tavares MS. Should pediatric idiopathic hypercalciuria be treated with hypocalciuric agents? World J Nephrol 2021; 10(4): 47-58
URL https://www.wjgnet.com/2220-6124/full/v10/i4/47.htm
DOI https://dx.doi.org/10.5527/wjn.v10.i4.47
Full Article (PDF) WJN-10-47.pdf
Full Article (Word) WJN-10-47.docx